TGA Approval

EVOCAIR ACCUHALER 250/50 fluticasone propionate 250 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack (208195)

ARTG ID

208195

ARTG Name

EVOCAIR ACCUHALER 250/50 fluticasone propionate 250 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack

Sponsor

GlaxoSmithKline Australia Pty Ltd

ARTG Date

May 7, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

GlaxoSmithKline Australia Pty Ltd

Sponsor Item Name

GLAXOSMITHKLINE AUSTRALIA PTY LTD

Active Ingredients

Ingredient Name

fluticasone propionate

Ingredient Name

salmeterol xinafoate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

EVOCAIR ACCUHALER 250/50 fluticasone propionate 250 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack (208195) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

EVOCAIR ACCUHALER 250/50 fluticasone propionate 250 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack (208195)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal